Patient study · n=563 · February 2026

Patient Study 2026

Hair Health Barometer
2026

A primary survey of 563 patients on the emotional burden, decision-making journeys and satisfaction surrounding hair transplantation. Conducted in February 2026.

563 Patients
70% Emotionally affected
96.1% Would recommend
41.9% Wait over 5 years
To the study
563 patients Direct interviews, no panels
February 2026 Current survey period
30 questions in focus Demographics, journey, satisfaction
Primary data Free to cite with attribution
Key findings

Six central results of the survey

The figures below capture the most important findings of the study. They shed light on how long those affected live with hair loss before treating it, how patients inform themselves and how they rate the treatment afterwards.

70%

Emotional burden

Seven in ten respondents say they experience hair loss as a strong or very strong emotional burden.

41.9%

More than five years of suffering

41.9% of patients say they had already lived with hair loss for longer than five years before they considered a hair transplant.

96.1%

Willingness to recommend

96.1% of respondents would recommend the treatment or at least consider doing so depending on the situation. Only 3.9% explicitly rule out a recommendation.

58.6%

Research via search engine

58.6% of patients name Google research as one of their information channels. Personal recommendations follow at 42.6% (multiple answers permitted).

96.6%

Gender distribution

96.6% of the patients surveyed are male and 3.2% female. The most common age group is 35 to 44 years.

22%

Critical perception

22% of respondents also associate hair transplant clinics with the term “production-line treatment”. At the same time, 67.9% rate the clinic that treated them as professional.

Chapter 01 · Demographics

Who took part?

The survey was aimed exclusively at people who have already completed a hair transplant. The composition of the sample offers an insight into the profile of those currently choosing this treatment.

96.6%
Male
3.2% of respondents are female and 0.2% gave no answer. The sample reflects the distribution typical of the sector.
35–44
Most common age group
35.3% fall within this range, followed by 45–54 (20.8%) and 25–34 (20.4%).
73.2%
In a relationship
47.1% married, 26.1% in a committed relationship. 22.4% are single with no steady partner.
54.5%
Have children
The majority of respondents have children of their own. 45.5% say they have none.

Occupations are broadly spread: the self-employed and business owners (16.9%), construction and trades (15.5%) and IT and engineering (14.6%) are the most strongly represented. The lifestyle questions reveal a high affinity for sports and exercise. This aligns with a further finding: 92.6% of respondents say that their outward appearance is important or very important to them.

Patients’ occupational fields

Self-employed & business owners16.9 %
Construction & trades15.5 %
IT & engineering14.6 %
Retail & sales14.0 %
Healthcare & social work11.5 %
Finance & insurance8.2 %

Lifestyle & interests (multiple answers)

Fitness & sports73.7 %
Travel & adventure56.1 %
Soccer/Football38.2 %
Fashion & styling35.3 %
Music & concerts30.4 %
Beauty & grooming23.1 %

Demographic snapshot

In sum, the sample describes a professionally active, middle-aged cohort with stable social ties. Net incomes range from under €2,000 (6.4%) to over €5,000 (17.9%), with a concentration between €2,000 and €3,500 (31.3%).

Chapter 02 · Time spent suffering & emotional burden

Years pass between the first symptoms and treatment.

A central result of the study concerns the span of time between the first noticeable hair loss and the moment treatment is considered. For most respondents this phase lasts several years and is frequently bound up with palpable emotional strain.

70%
Emotionally affected

70% of respondents describe the emotional burden as strong or very strong.

50.8% say hair loss had a strong influence on them and that they wanted to change something. 19.2% describe the burden as very strong. A further 22.2% rate it as moderate. Only 2.8% say they considered the treatment without any emotional motivation.

The study captures four points along the patient journey. They show that several years can pass between the first noticeable hair loss and treatment, and that price expectations often shift after booking.

5+ years
is how long 41.9% of patients wait between their first hair loss and the thought of treatment
💭
1+ year
is how long 43% deliberate actively, once they have finally allowed themselves to think about a hair transplant
👋
70%
feel strongly to very strongly burdened by the process before they act
86%
rate the price as fair or inexpensive after booking — the uncertainty was greater than the price

How long had the hair loss lasted before the thought of a hair transplant?

More than 5 years41.9 %
1 to 3 years28.1 %
3 to 5 years24.5 %
Less than 1 year5.5 %

How strongly did the hair loss influence the decision?

Strongly — wanted to change something50.8 %
Moderately — it was a good option22.2 %
Very strongly — emotionally heavily burdened19.2 %
Slightly — an improvement, not a must5.0 %
No burden — “because I could”2.8 %

Chapter 2 summary

94.5% of respondents had hair loss for at least a year before the thought of treatment, and 41.9% for longer than five years. 43% take a further year or more to reflect after that first consideration before booking the procedure.

Chapter 03 · Information sources

How do those affected inform themselves before a decision?

The study recorded which information channels patients used before their treatment. Multiple answers were permitted. The analysis shows that online research and personal recommendations are the two most frequently named sources.

58.6%
Google research
SEO and organic visibility are the primary entry channel.
42.6%
Personal recommendation
Word of mouth is the second most common and most trusted source.
36.6%
Social video
Instagram, TikTok and YouTube play a major role, especially among 25–44-year-olds.
28.2%
Forums & reviews
Communities and review portals actively shape the shortlist of clinics.

Taken together, the two most common channels — Google research and personal recommendation — account for over 100% in multiple-answer terms. A large share of respondents therefore combines independent online research with conversations in their social circle. Traditional advertising formats (print, TV, out-of-home) are mentioned only occasionally in the survey.

Striking is the high standing of user-generated content: reviews in forums (28.2%) and videos on platforms such as Instagram, TikTok or YouTube (36.6%) are named more often than traditional doctor recommendations. This suggests that patients actively compare and draw on independent sources before making their decision.

Chapter 3 summary

More than 70% of respondents reach their clinic through organic search or personal recommendation. The results suggest that patients base their decision on researchable, verifiable information.

Chapter 04 · Perception

Which terms do patients associate with their clinic?

In a multiple-choice question, participants could select positive as well as critical attributes. The questionnaire was deliberately designed to leave room for negative answers. The comparison below shows the most frequent positive associations and the most relevant critical perceptions.

Perception in contrast

🏆Professional
67.9% vs. 22%
Production-line treatment⚠️
67.9 %
22 %
🎓Competent
61.3% vs. 17.1%
Uncertain quality
61.3 %
17.1 %
💡Modern
54.5% vs. 9.6%
Personalized👤
54.5 %
9.6 %

Positive attributes dominate: professional (67.9%), competent (61.3%), modern (54.5%), likeable and customer-focused (35.7%) and innovative (29.5%).

At the same time, a critical pattern of perception is present: 22% of respondents also associate their clinic with the term “production-line treatment”, 17.1% cite uncertainty about quality, and only 9.6% describe the care they received as explicitly personalized. Elithair takes these results as an indicator that it should make individualized care processes such as the 5-doctor concept and the Pre-Test System even more visible to patients.

Chapter 4 summary

The perception among the patients surveyed is overwhelmingly positive (professionalism, competence, modernity). The critical share of 22% for “production-line treatment” is documented as a pointer toward further strengthening the personalization of care.

Chapter 05 · Satisfaction

Rating the treatment outcome

After completing their treatment, participants were asked how satisfied they were with the result and whether they would recommend the treatment. The two figures are closely linked.

93.7%

Satisfied with the result

93.7% rate the treatment outcome as anywhere from neutral to very satisfied. Only 6.3% express explicit dissatisfaction.

96.1%

Would consider recommending it

The range runs from “depending on the situation” to “absolutely”. Only 3.9% explicitly rule out a recommendation.

The two figures reinforce one another: 93.7% rating the result positively to neutrally meet 96.1% who are, in principle, willing to recommend it. The link between acceptance of the result and willingness to recommend is therefore clearly demonstrable and explains the high standing of personal recommendations as an information source documented in Chapter 3.

The assessment of the price after treatment is also clearly positive: 86.3% of respondents consider the price, in hindsight, to be fair or inexpensive (79% fair, 7.3% inexpensive). Only 13.7% rate it as expensive.

Participants’ open-ended answers

Everything was perfect, from being picked up at the airport to the operation.

Patient, positive feedback on the service experience

Product purchases from the shop should appear in the app — as individual appointments for the applications in the calendar.

Patient, suggestion on product and app integration

Respond more to individual concerns.

Patient, critical feedback

Chapter 5 summary

93.7% of respondents rate the result as anywhere from neutral to very satisfied, and 96.1% would recommend the treatment or at least consider it depending on the situation. The share of those explicitly dissatisfied is 6.3%, and those who flatly refuse to recommend it 3.9%. Acceptance of the result and willingness to recommend correlate clearly.

Chapter 06 · International context

Hair loss is a global care issue.

The German data gathered here can be set within a broader international context. National dermatological surveys and market analyses show that male hair loss reaches comparable levels in most Western and Arab states. The figures below come from published third-party sources.

🇩🇪

Germany & DACH

563

Respondents in this study. The core market with the deepest data foundation.

🇬🇧

United Kingdom

~47 %

Of men under 50 are affected by measurable hair loss. Source: British Journal of Dermatology.

🇫🇷

France

45 %

Of men over 35 show significant alopecia. High awareness, limited local provision.

🇸🇦

Saudi Arabia & UAE

Top 5

Hair transplantation is among the fastest-growing aesthetic procedures in the GCC region.

🇳🇱

Netherlands & Benelux

+28 %

Rise in demand for hair transplants since 2022. Growing medical tourism toward Istanbul.

🌐

Global market by 2030

$21bn

Projected global market volume for hair transplantation. Source: Grand View Research, 2024.

Medical commentary

Comment on the results

The figures presented here are placed in context by a brief expert statement from the medical director. It focuses on the findings that are central from a clinical perspective.

Expert comment

“The long period of suffering before the first treatment is the most striking finding.”

41.9% of respondents lived with hair loss for over five years before considering treatment. In parallel, 70% describe the emotional burden during this phase as strong to very strong. From a clinical perspective, both findings should be viewed together. They suggest that education on the causes, course and treatment options for androgenetic alopecia should accompany a longer phase than has been usual to date.

Dr Balwi · Medical Director, Elithair

Data free for editorial use

All figures in this study may be used in editorial and academic contexts with the attribution “Elithair Hair Health Barometer 2026, n=563”. For press inquiries, raw data or additional analyses, presse@elithair.de is available.

Citation

Cite the Hair Health Barometer

All content in this study may be used with attribution for editorial, academic and informational purposes. The templates below make correct citation easier.

📖 Ready-to-copy citation templates

Ready-made citations in three formats

Ready to drop into academic work, articles and blog posts. Would you like raw data, high-resolution graphics or an interview with Dr Balwi? Write to us at press@elithair.de.

Elithair. (2026). Hair Health Barometer 2026: Patient study on hair loss and hair transplantation (n=563). Elithair, Istanbul. https://elithair.com/hair-health-barometer-2026/
Elithair (2026) Hair Health Barometer 2026: Patient study on hair loss and hair transplantation, n=563. Available at: https://elithair.com/hair-health-barometer-2026/
Source: Elithair Hair Health Barometer 2026, primary survey of n=563 patients, February 2026. Available at elithair.com/hair-health-barometer-2026.
Elithair Hair Health Barometer 2026, n=563.
Methodology & transparency

How the study was conducted

The following details on the sample, period, question set and limitations allow for a well-founded interpretation of the results.

Sample

n = 563Patients from the Elithair network

Survey period

February 2026Structured one-off survey

Question set

30 questionsClosed & open, with multiple choice

Inclusion criterion

Completed hair transplantAt least one treatment at Elithair

Topic areas of the survey: demographics, lifestyle, decision-making journey and time spent suffering, information sources, brand perception, experience with the Dr Balwi shop, satisfaction with the result and willingness to recommend. Multiple answers were permitted in the areas of interests and information sources, so individual totals there exceed 100%.

Limitations: this is a patient survey within a clinic network, not a representative population poll. The sample is therefore suited to depicting the journey, motivation and satisfaction within the target group actually treated — not to making statements about the overall population affected by hair loss. No sample weighting was applied.

Data protection: all data was processed anonymously. No patient is identifiable in the published results. Quotes were used with the consent of the respective patients.

Frequently asked questions about the study

May we use individual graphics in our own articles?

Yes. Individual percentages, quotes and figures may be used editorially with the attribution “Elithair Hair Health Barometer 2026, n=563”. For more extensive use, such as wholesale redesigns of graphics, we would appreciate a brief note to press@elithair.de.

Is the study available as a PDF or press kit?

A press kit with a PDF, high-resolution graphics and raw-data tables can be requested informally at press@elithair.de. For editorial purposes the material is usually provided within 48 hours.

Is an interview with Dr Balwi possible?

Yes. Please send requests for press interviews, podcasts or specialist articles to press@elithair.de. Dr Balwi is also available on request for English-language formats.

Is there a plan to repeat the study regularly?

Yes. The Hair Health Barometer is designed as an annual primary survey. The development of key figures such as time spent suffering, emotional burden and patterns of perception will be documented across several survey years.

Am I a candidate?